My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
A phase 2 clinical trial using a new technology show it is possible to induce immune tolerance to gluten in individuals with celiac disease. After treatment with the technology, the patients were able to eat gluten with a substantial reduction in inflammation.
Source: New treatment may reverse celiac disease
I have a strong affinity for the sciences which led me to create my sites. My compulsion for the past decade has been reviewing literally every peer-reviewed research article. Which can easily be validated by following my posts. To me, science is where the real news is, as it will mold our destiny beyond that of politics or economics. ;-)
Subscribe now to keep reading and get access to the full archive.